Not
Just for Kids Anymore – Appropriate Treatment and Management of
Attention Deficit Hyperactivity Disorder (ADHD) in Adults
Please
read through the following information and click continue.
ACPE Universal Program Number:
207-000-08-133-H01-P
and 207-000-08-133-H01-T
Release
Date: October 14, 2008
Expiration Date: October 14, 2011
Statement
of Need
The
prevalence of Attention Deficit Hyperactivity Disorder (ADHD) in adults
is thought to be around 4.4% of the adult population, or more than 8
million people. It is now known that these symptoms continue into
adulthood for about 60% of children with ADHD. However, few adults are
identified or treated for adult ADHD. Without proper treatment, these
individuals can experience behavioral, emotional, social, vocational
and academic problems. In adulthood, these patients may now present
with other health conditions that were not a concern during childhood.
Pharmacists can play a key role in potential identification of undiagnosed and undertreated ADHD, as well as the management of ADHD drug therapy due to their frequent interaction with not only the patient, but other health care providers as well. Pharmacists' level of patient exposure makes the community pharmacist a prime candidate to provide patients with education on adult ADHD and treatment options, ongoing personal and emotional support, and regular monitoring for potential adverse events related to drug therapy. Additionally, pharmacists are in the best position to monitor for drug interactions between ADHD drug therapy and therapy for other health conditions possibly being treated by multiple prescribers.
Learning
Objectives
Upon
successful completion of this activity, the pharmacist should be able
to:
- Discuss the prevalence and symptoms of adult ADHD.
- Describe pharmacologic and non-pharmacologic treatment options for adult ADHD.
- Discuss appropriate counseling of patients on proper ADHD medication use.
- Describe proper handling of adverse events, complications, and drug interactions with treatment options used in adult patients with ADHD.
Target
Audience
The
target market for this program is pharmacists and pharmacy technicians.
Instructions
for Participation
To
receive a certificate of completion that indicates your eligibility for
continuing education credit, you must:
- Review the content of the activity.
- Successfully complete the post-test (70% or higher).
- You will have two (2) opportunities to successfully complete the activity.
Your statement of credit will be issued immediately upon successful completion of the post-test and submission of the evaluation.
Fee
There
is no fee for this activity.
Accreditation
Pharmacists
NCPA is accredited by the Accreditation Council
for Pharmacy Education as a provider of continuing pharmacy education.
This program will provide 1.5 contact hours (.15 CEUs) of continuing
pharmacy education credit under the number 207-000-08-133-H01-P
and 207-000-08-133-H01-T.
Faculty
J.
Daniel Justino, PharmD, BCPP (click here to view bio)
Clinical Specialist in Psychiatry
Bay Pines VAHCS
Bay Pines, Florida
Disclosure
Declaration
It
is the policy of the National Community Pharmacists Association (NCPA)
to ensure independence, balance, objectivity, scientific rigor, and
integrity in all of their continuing education activities.
The author, sponsor, and publisher of this continuing education activity have made all reasonable efforts to ensure that information contained herein is accurate in accordance with the latest available scientific knowledge at the time of accreditation of this continuing education program. Information regarding drugs (e.g., their administration, dosages, contraindications, adverse reactions, interactions, special warnings, precautions) and drug delivery systems are subject to change, however, and the reader is advised to check the manufacturer's package insert for information concerning recommended dosage and potential problems or cautions prior to dispensing or administering the drug or using the drug delivery systems.
Approval of credit for this continuing education activity does not imply endorsement by NCPA of any product or manufacturer identified.
Any medications or treatment methods suggested in this CE activity should not be used by the practitioner without evaluation of their patient's condition(s) and possible contraindication(s) or danger(s) of use of any specific medication.
Commercial
Support Statement
Commercial
support provided by Ortho McNeil Janssen.
Software Requirements
|
PC *Required to view Printable PDF Version |
MAC |